Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.
- DOI
- 10.1038/s41416-019-0506-6
- Published
- 2019 Jul
- Container
- British journal of cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41416-019-0506-6,
title = {Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.},
author = {Evans TRJ and Kudo M and Finn RS and Han KH and Cheng AL and Ikeda M and Kraljevic S and Ren M and Dutcus CE and Piscaglia F and Sung MW},
year = {2019},
journal = {British journal of cancer},
doi = {10.1038/s41416-019-0506-6},
url = {https://doi.org/10.1038/s41416-019-0506-6}
}RIS
TY - JOUR TI - Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma. AU - Evans TRJ AU - Kudo M AU - Finn RS AU - Han KH AU - Cheng AL AU - Ikeda M AU - Kraljevic S AU - Ren M AU - Dutcus CE AU - Piscaglia F AU - Sung MW PY - 2019 JO - British journal of cancer DO - 10.1038/s41416-019-0506-6 UR - https://doi.org/10.1038/s41416-019-0506-6 ER -
APA
TRJ, E., M, K., RS, F., KH, H., AL, C., M, I., S, K., M, R., CE, D., F, P., & MW, S. (2019). Urine protein:creatinine ratio vs 24-hour urine protein for proteinuria management: analysis from the phase 3 REFLECT study of lenvatinib vs sorafenib in hepatocellular carcinoma.. British journal of cancer. https://doi.org/10.1038/s41416-019-0506-6
Source records
- pubmed · retrieved 2026-09-27T16:30:22.561Z